Age-Related Macular Degeneration Market Competitive Landscape, Growth Factors, Revenue Analysis Till 2027
The growing awareness of AMD and the increasing geriatric population are anticipated to exhibit more opportunities for the growth of the age-related macular degeneration market . Moreover, as per the Community Eye Health Journal published in 2014 by the London School of Hygiene and Tropical Medicine, nearly 196 million people are estimated to suffer from age-related macular degeneration by 2020 worldwide. The global market for age-related macular degenerations is expected to grow at a CAGR of approximately 7.3% during the forecast period. Regionally, the Americas age-related macular degeneration market is segmented into two major regions, namely, North America and South America. Treatments targeting biochemical pathways implicated in the macular degeneration pathophysiology of ARMD are being tested actively in clinical trials The Americas region holds the largest share of the global age-related macular degeneration market owing to the increasing cases of macular de...